Celldex Therapeutics, Inc. (CLDX) SEC filings

Name: Celldex Therapeutics, Inc. (CLDX) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0000744218 · In Vitro & In Vivo Diagnostic Substances (SIC 2835) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

	FY2025	FY2024
Revenue (USD)	1.5 M	2.4 M
Diluted EPS (USD/shares)	-3.9	-2.4

Latest filings

Filed	Form	Description	Period
2026-10-07	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-09-22	8-K	FORM 8-K items 8.01,9.01	2026-09-22
2026-08-14	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-08-14	SCHEDULE 13G	SCHEDULE 13G
2026-08-06	10-Q	10-Q	2026-06-30
2026-08-06	8-K	FORM 8-K items 2.02,9.01	2026-08-06
2026-07-15	8-K	FORM 8-K items 5.02,9.01	2026-07-10
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25
2026-06-29	4	4	2026-06-25

Forms on file (last 1,000): 4 389, 8-K 182, SC 13G/A 73, 10-Q 57, SC 13G 37, 3 30, 424B5 29, SCHEDULE 13G/A 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CLDX (0.002 USD), /gw/filings/filings?ticker=CLDX&form=8-K, /gw/filings/facts?ticker=CLDX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange